scholarly article | Q13442814 |
P356 | DOI | 10.1111/J.1530-0277.1992.TB00697.X |
P698 | PubMed publication ID | 1335220 |
P2093 | author name string | Suzuki Y | |
Sano H | |||
Yokoyama T | |||
Ohara K | |||
Ishigaki T | |||
Yazaki R | |||
P2860 | cites work | Influence of dopamine agonists on plasma and brain levels of homovanillic acid | Q48933087 |
A comparison of plasma homovanillic acid concentrations in schizophrenic patients and normal controls | Q48957224 | ||
The diurnal variation in plasma homovanillic acid level persists but the variation in 3-methoxy-4-hydroxyphenylglycol level is abolished under constant conditions | Q48960763 | ||
Estimation of human blood plasma 5-hydroxyindoleacetic acid and homovanillic acid | Q33260241 | ||
The treatment of alcohol withdrawal | Q38669841 | ||
NIH conference. Alcohol withdrawal and noradrenergic function | Q39159254 | ||
Changes in monoamine concentrations in mouse brain associated with ethanol dependence and withdrawal | Q41874766 | ||
3,4-Dihydroxyphenylacetic acid and homovanillic acid in rat plasma: Possible indicators of central dopaminergic activity | Q43513468 | ||
Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients. Correlation with psychosis and response to neuroleptic treatment | Q44853637 | ||
A comparison of the effects of chronic administration of ethanol and acetaldehyde to mice: evidence for a role of acetaldehyde in ethanol dependence | Q48569590 | ||
Acute and chronic effects of neuroleptic drugs on plasma and brain homovanilic acid in the rat | Q48630734 | ||
Circadian changes in homovanillic acid and ascorbate levels in the rat striatum using microprocessor-controlled voltammetry | Q48858324 | ||
Circadian variation of plasma homovanillic acid levels is attenuated by fluphenazine in patients with schizophrenia | Q48923783 | ||
P433 | issue | 6 | |
P921 | main subject | circadian rhythm | Q208353 |
P304 | page(s) | 1047-1051 | |
P577 | publication date | 1992-12-01 | |
P1433 | published in | Alcoholism: Clinical and Experimental Research | Q4713331 |
P1476 | title | Circadian variation in plasma homovanillic acid level during and after alcohol withdrawal in alcoholic patients | |
P478 | volume | 16 |
Q44253186 | A genotype-controlled analysis of plasma dopamine beta-hydroxylase in healthy and alcoholic subjects: evidence for alcohol-related differences in noradrenergic function |
Q28541316 | A heuristic model of alcohol dependence |
Q35146112 | Alcohol and withdrawal: from animal research to clinical issues |
Q72079719 | Circadian variation in plasma 5‐hydroxyindoleacetic acid level during and after alcohol withdrawal: phase advances in alcoholic patients compared with normal subjects |
Q46776535 | DBH*444G/A polymorphism of the dopamine-beta-hydroxylase gene is associated with alcoholism but not with severe alcohol withdrawal symptoms. |
Q41261444 | Detection of new human metabolic urinary markers in chronic alcoholism and their reversal by aqueous extract of Tinospora cordifolia stem. |
Q71370134 | Evidence for prolonged recovery of dopaminergic transmission after detoxification in alcoholics with poor treatment outcome |
Q36717483 | Genetic polymorphisms related to delirium tremens: a systematic review |
Q44443824 | Homovanillic acid (HVA) plasma levels inversely correlate with attention deficit-hyperactivity and childhood neglect measures in addicted patients. |
Q33945794 | Impaired sleep during the post-alcohol withdrawal period in alcoholic patients |
Q41159382 | Pharmacotherapies for alcohol problems: a review of research with focus on developments since 1991. |
Q44437032 | Plasma homovanillic acid: a significant association with alcoholism is independent of a functional polymorphism of the human catechol-O-methyltransferase gene. |
Q44224065 | Risk for delirium tremens in patients with alcohol withdrawal syndrome |
Q52994373 | β-Carbolines in alcohol-dependent intensive care patients during prophylactics and therapy of alcohol withdrawal syndrome. |